Published findings determined that, for patients with chronic kidney disease and major depressive disorder, higher concentrations of the inflammatory biomarker hsCRP were associated with both improvement and response to the antidepressant sertraline.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.
